{"id":883,"date":"2017-02-20T14:08:21","date_gmt":"2017-02-20T13:08:21","guid":{"rendered":"http:\/\/sites.unimi.it\/SSPA\/?page_id=883"},"modified":"2018-03-07T16:14:17","modified_gmt":"2018-03-07T16:14:17","slug":"irving-wainer","status":"publish","type":"page","link":"https:\/\/sites.unimi.it\/SSPA\/2017\/irving-wainer\/","title":{"rendered":"Irving Wainer"},"content":{"rendered":"<p>[et_pb_section admin_label=&#8221;section&#8221;][et_pb_row admin_label=&#8221;row&#8221;][et_pb_column type=&#8221;1_4&#8243;][et_pb_image admin_label=&#8221;Image&#8221; src=&#8221;http:\/\/sites.unimi.it\/SSPA\/SSPA2017\/wp-content\/uploads\/sites\/2\/2017\/02\/waienr.png&#8221; show_in_lightbox=&#8221;off&#8221; url_new_window=&#8221;off&#8221; use_overlay=&#8221;off&#8221; animation=&#8221;left&#8221; sticky=&#8221;off&#8221; align=&#8221;left&#8221; force_fullwidth=&#8221;off&#8221; always_center_on_mobile=&#8221;on&#8221; use_border_color=&#8221;off&#8221; border_color=&#8221;#ffffff&#8221; border_style=&#8221;solid&#8221;] [\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;3_4&#8243;][et_pb_text admin_label=&#8221;Text&#8221; background_layout=&#8221;light&#8221; text_orientation=&#8221;left&#8221; use_border_color=&#8221;off&#8221; border_color=&#8221;#ffffff&#8221; border_style=&#8221;solid&#8221;]<\/p>\n<p><strong>Professor Irving W Wainer<\/strong> is Chief Scientific Office for Mitchell Woods Pharmaceuticals. He received his PhD degree in chemistry from Cornell University and did postdoctoral doctoral studies in molecular biology (University of Oregon) and clinical pharmacology (Thomas Jefferson Medical School).\u00a0 He worked for the FDA as a Research Chemist, at St. Jude\u2019s Children&#8217;s Research Hospital (Associate Member), McGill University (Professor, Department of Oncology), Georgetown University (Professor, Department of Pharmacology) and as Senior Investigator, National Institute on Aging\/NIH.\u00a0 Professor Wainer has published 390 scientific papers, 10 books, holds 11 patents, was Founding Editor of the journal Chirality and Senior Editor of the Journal of Chromatography B. His awards include: the &#8220;A.J.P. Martin Medal&#8221; presented by The Chromatographic Society; Elected Fellow of the American Academy of Pharmaceutical Sciences; Doctor Honoris Causa degrees awarded by the Medical University of Gdansk and University of Liege, the 2013 Dal Nogare Award and the 2013 Eastern Analytical Symposium Award for Outstanding Contributions to the Fields of Analytical Chemistry. Prof. Wainer\u2019s laboratory is also engaged in studies that employ targeted and non-targeted pharmacometabolomics, molecular and cellular biology, cellular pharmacology and pharmacokinetics-pharmacodynamics, as well as chemometric analysis of the data obtained from these studies. Professor Wainer\u2019s laboratory is currently engaged in the development of new therapeutic agents for the treatment of oncologic and CNS diseases and the translation of these agents from the laboratory to the clinic.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[et_pb_section admin_label=&#8221;section&#8221;][et_pb_row admin_label=&#8221;row&#8221;][et_pb_column type=&#8221;1_4&#8243;][et_pb_image admin_label=&#8221;Image&#8221; src=&#8221;http:\/\/sites.unimi.it\/SSPA\/SSPA2017\/wp-content\/uploads\/sites\/2\/2017\/02\/waienr.png&#8221; show_in_lightbox=&#8221;off&#8221; url_new_window=&#8221;off&#8221; use_overlay=&#8221;off&#8221; animation=&#8221;left&#8221; sticky=&#8221;off&#8221; align=&#8221;left&#8221; force_fullwidth=&#8221;off&#8221; always_center_on_mobile=&#8221;on&#8221; use_border_color=&#8221;off&#8221; border_color=&#8221;#ffffff&#8221; border_style=&#8221;solid&#8221;] [\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;3_4&#8243;][et_pb_text admin_label=&#8221;Text&#8221; background_layout=&#8221;light&#8221; text_orientation=&#8221;left&#8221; use_border_color=&#8221;off&#8221; border_color=&#8221;#ffffff&#8221; border_style=&#8221;solid&#8221;] Professor Irving W Wainer is Chief Scientific Office for Mitchell Woods Pharmaceuticals. He received his PhD degree in chemistry from Cornell University and did postdoctoral doctoral studies in molecular biology [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/sites.unimi.it\/SSPA\/2017\/wp-json\/wp\/v2\/pages\/883"}],"collection":[{"href":"https:\/\/sites.unimi.it\/SSPA\/2017\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sites.unimi.it\/SSPA\/2017\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sites.unimi.it\/SSPA\/2017\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.unimi.it\/SSPA\/2017\/wp-json\/wp\/v2\/comments?post=883"}],"version-history":[{"count":1,"href":"https:\/\/sites.unimi.it\/SSPA\/2017\/wp-json\/wp\/v2\/pages\/883\/revisions"}],"predecessor-version":[{"id":1047,"href":"https:\/\/sites.unimi.it\/SSPA\/2017\/wp-json\/wp\/v2\/pages\/883\/revisions\/1047"}],"wp:attachment":[{"href":"https:\/\/sites.unimi.it\/SSPA\/2017\/wp-json\/wp\/v2\/media?parent=883"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}